An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy

Condition:   Chronic Hepatitis b Interventions:   Drug: TDF tablet;   Drug: Entecavir Tablet;   Drug: QL-007 Sponsor:   Qilu Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials